EMILIN1 and neoplasm: A tumor-suppressive role has been observed upon epigenetic silencing via promoter hypermethylation, which reduces EMILIN-1 expression in fusion-positive rhabdomyosarcoma [55] and uterine carcinosarcoma, particularly in carcinomatous components [56].